Filtered By:
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 244 results found since Jan 2013.
Delayed hypersensitivity to the Comirnaty COVID-19 vaccine presenting with pneumonitis and rash
Ann Allergy Asthma Immunol. 2021 Nov 20:S1081-1206(21)01274-6. doi: 10.1016/j.anai.2021.11.014. Online ahead of print.NO ABSTRACTPMID:34813953 | PMC:PMC8605811 | DOI:10.1016/j.anai.2021.11.014
Source: Annals of Allergy, Asthma and Immunology - November 23, 2021 Category: Allergy & Immunology Authors: Dr Alex Stoyanov Dr Graeme Thompson Dr Monique Lee Professor Connie Katelaris Source Type: research
Delayed hypersensitivity to the Comirnaty coronavirus disease 2019 vaccine presenting with pneumonitis and rash
Clinical trials have supported the efficacy of vaccines for the prevention of coronavirus disease 2019(COVID-19) infection, and widespread vaccination is now seen as a cornerstone in preventing mortality.1 Postapproval surveillance has however revealed rare but significant vaccine-associated complications, including thrombosis with thrombocytopenia syndrome after the adenovirus vector ChAdOX1-S and Janssen vaccines2 and myocarditis with messenger RNA –based vaccines.3 This has highlighted the importance of ongoing pharmacovigilance and prompt reporting of suspected vaccine-associated adverse events.
Source: Annals of Allergy, Asthma and Immunology - November 20, 2021 Category: Allergy & Immunology Authors: Alex Stoyanov, Graeme Thompson, Monique Lee, Connie Katelaris Tags: Letters Source Type: research
Delayed hypersensitivity to the Comirnaty COVID-19 vaccine presenting with pneumonitis and rash
Clinical trials have supported the efficacy of vaccines for the prevention of COVID-19 infection and widespread vaccination is now seen as a cornerstone in preventing mortality.1 Post-approval surveillance has however demonstrated rare but significant vaccine associated complications, including thrombosis with thrombocytopenia syndrome following the adenovirus vector ChAdOX1-S and Janssen vaccines2 and myocarditis with mRNA-based vaccines.3 This has highlighted the importance of ongoing pharmacovigilance and prompt reporting of suspected vaccine associated adverse events.
Source: Annals of Allergy, Asthma and Immunology - November 20, 2021 Category: Allergy & Immunology Authors: Dr Alex Stoyanov, Dr Graeme Thompson, Dr Monique Lee, Professor Connie Katelaris Source Type: research
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection
In conclusion, findings indicated that peptides derived from outer membrane protein-A can be used as a promising tool for designing the epitope-based vaccines against infections caused by A. baumannii.PMID:34664813 | DOI:10.18502/ijaai.v20i5.7404
Source: Iranian Journal of Allergy, Asthma and Immunology - October 19, 2021 Category: Allergy & Immunology Authors: Kobra Mehdinejadiani Ali Hashemi Mojgan Bandehpour Hoda Rahmani Mohammad Mehdi Ranjbar Vahid Yardel Seyed Amir Jalali Nariman Mosaffa Source Type: research
